11 October 2017. Piramal Pharma Solutions (PPS) is set to invest $55m across its production sites in North America and Asia in order to expand its active pharmaceutical ingredients (API) manufacturing capabilities and capacities.

PHARMACEUTICALTECHNOLOGY.COM

http://www.pharmaceutical-technology.com/news/newspiramal-to-invest-55m-on-api-manufacturing-capabilities-5944848

At industryabout.com:

Piramal World Facilities

 

You can post comments after registration